Luca Gentile

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

Andrea Cortese, Giuseppe Vita, Marco Luigetti et al. · Journal of Neurology · 2016 · 96 citations · Full text

Medicine, Neurology, Pathology +4

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

Anna Mazzeo, Massimo Russo, Gianluca Di Bella et al. · Journal of Neuromuscular Diseases · 2015 · 91 citations · Full text

Life Sciences, Genetics, Neurology +12

ATTRv amyloidosis Italian Registry: clinical and epidemiological data

Massimo Russo, Laura Obici, Ilaria Bartolomei et al. · Amyloid · 2020 · 90 citations

Life Sciences, Genetics, Neurology +13

A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Luca Gentile, Teresa Coelho, Angela Dispenzieri et al. · Orphanet Journal of Rare Diseases · 2023 · 71 citations · Full text

Life Sciences, Pathology, Clinical Epidemiology +13